{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:02:51Z","timestamp":1787166171887,"version":"build-2736575974"},"reference-count":142,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T00:00:00Z","timestamp":1594080000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasitol Res"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s00436-020-06786-1","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T15:05:08Z","timestamp":1594134308000},"page":"2749-2764","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Enhancing the antimalarial activity of artesunate"],"prefix":"10.1007","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3151-2247","authenticated-orcid":false,"given":"J. O.","family":"Adebayo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tijjani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. P.","family":"Adegunloye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. A.","family":"Ishola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. A.","family":"Balogun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. O.","family":"Malomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,7]]},"reference":[{"issue":"3","key":"6786_CR1","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0960327111424298","volume":"31","author":"JO Adebayo","year":"2012","unstructured":"Adebayo JO, Santana AE, Krettli AU (2012) Evaluation of the antiplasmodial and cytotoxicity potentials of husk fibre extracts from Cocos nucifera, a medicinal plant used in Nigeria to treat human malaria. Hum Exp Toxicol 31(3):244\u2013249","journal-title":"Hum Exp Toxicol"},{"key":"6786_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/742476","volume":"2013","author":"JO Adebayo","year":"2013","unstructured":"Adebayo JO, Balogun EA, Malomo SO, Soladoye AO, Olatunji LA, Kolawole OM, Oguntoye OS, Babatunde AS, Akinola OB, Aguiar ACC, Andrade IM, Souza NB, Krettli AU (2013) Antimalarial activity of Cocos nucifera husk fibre: further studies. Evid Based Complement Alternat Med 2013:1\u20139","journal-title":"Evid Based Complement Alternat Med"},{"issue":"9315","key":"6786_CR3","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0140-6736(02)08348-4","volume":"359","author":"M Adjuik","year":"2002","unstructured":"Adjuik M, Agnamey P, Babiker A, Borrmann S, Brasseur P, Cisse M, Cobelens F, Diallo S, Faucher JF, Garner P, Gikunda S, Kremsner PG, Krishna S, Lell B, Loolpapit M, Matsiegui PB, Missinou MA, Mwanza J, Ntoumi F, Olliaro P, Osimbo P, Rezbach P, Some E, Taylor WR (2002) Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomised, multicentre trial. Lancet 20 359(9315):1365\u20131372","journal-title":"Lancet 20"},{"issue":"9988","key":"6786_CR4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)60721-8","volume":"386","author":"ST Agnandji","year":"2015","unstructured":"Agnandji ST, Lell B, Soulanoudjingar SS et al (2015) Clinical trials partnership efficacy and safety of RTS,S\/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet 386(9988):31\u201345","journal-title":"Lancet"},{"key":"6786_CR5","first-page":"1061","volume":"11","author":"M Al-Qaraghuli","year":"2017","unstructured":"Al-Qaraghuli M, Alzahrani A, Niwasabutra K, Obeid M, Ferro V (2017) Where traditional drug discovery meets modern technology in the quest for new drugs. Ann Pharmacol Pharmaceutics 11:1061","journal-title":"Ann Pharmacol Pharmaceutics"},{"key":"6786_CR6","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1038\/s41598-018-21351-8","volume":"8","author":"SA Amolegbe","year":"2018","unstructured":"Amolegbe SA, Hirano Y, Adebayo JO, Ademowo OG, Balogun EA, Obaleye JA, Krettli AU, Yu C, Hayami S (2018) Mesoporous silica nanocarriers encapsulated antimalarials with high therapeutic performance. Sci Rep 8:3078\u20133086","journal-title":"Sci Rep"},{"key":"6786_CR7","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1186\/1475-2875-11-316","volume":"11","author":"MP Anthony","year":"2012","unstructured":"Anthony MP, Burrows JN, Duparc S, Moehrle JJ, Wells TN (2012) The global pipeline of new medicines for the control and elimination of malaria. Malar J 11:316","journal-title":"Malar J"},{"key":"6786_CR8","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1086\/424663","volume":"39","author":"JK Baird","year":"2004","unstructured":"Baird JK, Hoffman SL (2004) Primaquine therapy for malaria. Clin Infect Dis 39:1336\u20131345","journal-title":"Clin Infect Dis"},{"key":"6786_CR9","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/S0140-6736(04)16203-X","volume":"363","author":"KI Barnes","year":"2004","unstructured":"Barnes KI, Mwenechanya J, Tembo M, McIlleron H, Folb PI, Ribeiro I, Little F, Gomes M, Molyneux ME (2004) Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study. Lancet 363:1598\u20131605","journal-title":"Lancet"},{"key":"6786_CR10","doi-asserted-by":"crossref","first-page":"11221","DOI":"10.1021\/cr500543f","volume":"114","author":"DS Barnett","year":"2014","unstructured":"Barnett DS, Guy RK (2014) Antimalarials in development in 2014. Chem Rev 114:11221\u201311241","journal-title":"Chem Rev"},{"key":"6786_CR11","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.2042-7158.1996.tb05870.x","volume":"48","author":"KT Batty","year":"1996","unstructured":"Batty KT, Ilett KF, Davis T (1996) Chemical stability of artesunate injection and proposal for its administration by intravenous infusion. J Pharm Pharmacol 48:22\u201326","journal-title":"J Pharm Pharmacol"},{"key":"6786_CR12","doi-asserted-by":"crossref","unstructured":"Bhisutthibhan J, Meshnick SR (2001) Immunoprecipitation of [3H]dihydroartemisinin translationally controlled tumor protein (TCTP) adducts from Plasmodium falciparum-infected erythrocytes by using anti-TCTP antibodies. Antimicrob Agents Chemother 45(8):2397\u20132399","DOI":"10.1128\/AAC.45.8.2397-2399.2001"},{"key":"6786_CR13","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1568012043354008","volume":"3","author":"C Biot","year":"2004","unstructured":"Biot C (2004) Ferroquine: a new weapon in the fight against malaria. Curr Med Chem Anti Infect Agents 3:135\u2013147","journal-title":"Curr Med Chem Anti Infect Agents"},{"key":"6786_CR14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1021\/mp0500061","volume":"2","author":"C Biot","year":"2005","unstructured":"Biot C, Taramelli D, Forfar-Bares I, Maciejewski LA, Boyce M, Nowogrocki G, Brocard JS, Basilico N, Olliaro P, Egan TJ (2005) Insights into the mechanism of action of ferroquine relationship between physicochemical properties and antiplasmodial activity. Mol Pharmaceutics 2:185\u2013193","journal-title":"Mol Pharmaceutics"},{"key":"6786_CR15","unstructured":"Boechat N, Souza MVN, Valverde AL, Krettli AU (2014) Compounds derived from artesunate, preparation process, pharmaceutical composition and use of the respective medicine. US Patent 8,071,777 B2"},{"issue":"2","key":"6786_CR16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1039\/cs9922100085","volume":"21","author":"AR Butler","year":"1992","unstructured":"Butler AR, Wu YL (1992) Artemisinin (Qinghaosu): a new type of antimalarial drug. Chem Soc Rev 21(2):85\u201390","journal-title":"Chem Soc Rev"},{"key":"6786_CR17","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1046\/j.1523-1755.2001.0590031044.x","volume":"59","author":"SB Campos","year":"2001","unstructured":"Campos SB, Rouch LHK, Seguro AC (2001) Effects of sodium artesunate, a new antimalarial drug, on renal function. Kidney Int 59:1044\u20131051","journal-title":"Kidney Int"},{"key":"6786_CR18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.rinphs.2011.07.002","volume":"1","author":"R Chadha","year":"2011","unstructured":"Chadha R, Gupta S, Shukla G, Jain DVS, Pissurlenkar RRS, Coutinho EC (2011) Interaction of artesunate with \u03b2-cyclodextrin: characterization, thermodynamic parameters, molecular modeling, effect of PEG on complexation and antimalarial activity. Results Pharma Sci 1:38\u201348","journal-title":"Results Pharma Sci"},{"issue":"3","key":"6786_CR19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v29.i3.10","volume":"29","author":"R Chadha","year":"2012","unstructured":"Chadha R, Saini A, Arora P, Bhandari S (2012) Pharmaceutical co-crystals: a novel approach for oral bioavailability enhancement of drugs. Crit Rev Ther Drug Carrier Syst 29(3):183\u2013218","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"6786_CR20","first-page":"313","volume-title":"Opportunity, challenge and scope of natural products in medicinal chemistry","author":"D Chaturvedi","year":"2011","unstructured":"Chaturvedi D (2011) Sesquiterpene lactones: structural diversity and their biological activities. In: Tiwari VK, Mishra BB (eds) Opportunity, challenge and scope of natural products in medicinal chemistry. Research Signpost, Kerala, pp 313\u2013334"},{"key":"6786_CR21","unstructured":"Chekem L, Wierucki S (2006) Extraction de l'art\u00e9misinine et synth\u00e8se de ses d\u00e9riv\u00e9s art\u00e9sunate et art\u00e9m\u00e9ther [Extraction of artemisinin and synthesis of its derivates artesunate and artemether]. Med Trop (Mars) 66(6):602\u2013605"},{"key":"6786_CR22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1021\/np9605246","volume":"60","author":"K Cimanga","year":"1997","unstructured":"Cimanga K, Bruyne TD, Pieters L, Vlietinck AJ, Turger CA (1997) In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta. J Nat Prod 60:688\u2013691","journal-title":"J Nat Prod"},{"key":"6786_CR23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ejmech.2014.01.040","volume":"76","author":"TT Cloete","year":"2014","unstructured":"Cloete TT, Kock C, Smith PJ, N\u2019da DD (2014) Synthesis, in vitro antiplasmodial activity and cytotoxicity of a series of artemisinin etriazine hybrids and hybrid-dimers. Eur J Med Chem 76:470\u2013481","journal-title":"Eur J Med Chem"},{"issue":"8","key":"6786_CR24","doi-asserted-by":"crossref","first-page":"e02214","DOI":"10.1128\/AAC.02214-17","volume":"62","author":"D Coertzen","year":"2018","unstructured":"Coertzen D, Reader J, van der Watt M, Nondaba SH, Gibhard L, Wiesner L, Smith P, D'Alessandro S, Taramelli D, Wong HN, du Preez JL, Wu RWK, Birkholtz LM, Haynes RK (2018) Artemisone and artemiside are potent panreactive antimalarial agents that also synergize redox imbalance in Plasmodium falciparum transmissible gametocyte stages. Antimicrob Agents Chemother 62(8):e02214\u2013e02217","journal-title":"Antimicrob Agents Chemother"},{"key":"6786_CR25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bmcl.2014.11.064","volume":"25","author":"RC Conyers","year":"2015","unstructured":"Conyers RC, Mazzone JR, Tripathi AK, Sullivan DJ, Posner GH (2015) Antimalarial chemotherapy: orally curative artemisinin-derived trioxane dimer esters. Bioorg Med Chem Lett 25:245\u2013248","journal-title":"Bioorg Med Chem Lett"},{"key":"6786_CR26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/1475-2875-11-270","volume":"11","author":"SL Croft","year":"2012","unstructured":"Croft SL, Duparc S, Arbe-Barnes SJ, Craft JC, Shin CS, Fleckenstein L, Borghini-Fuhrer I, Rim HJ (2012) Review of pyronaridine anti-malarial properties and product characteristics. Malarial J 11:270\u2013298","journal-title":"Malarial J"},{"key":"6786_CR27","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/j.1365-2125.2006.02601.x","volume":"61","author":"BT Cuong","year":"2006","unstructured":"Cuong BT, Binh VQ, DaiB DDN, Lovell CM, Rickman KH, Edstein MD (2006) Does gender, food or grapefruit juice alter the pharmacokinetics of primaquine in healthy subjects? Br J Clin Pharmacol 61:682\u2013689","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"6786_CR28","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1128\/AAC.00394-06","volume":"50","author":"EL Dahl","year":"2006","unstructured":"Dahl EL, Shock JL, Shenai BR, Gut J, DeRisi JL, Rosenthal PJ (2006) Tetracyclines specifically target the apicoplast of the malaria parasite Plasmodium falciparum. Antimicrob Agents Chemother 50(9):3124\u20133131","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"6786_CR29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMcp070747","volume":"357","author":"RS Daum","year":"2007","unstructured":"Daum RS (2007) Clinical practice skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus. N Engl J Med 357(4):380\u2013390","journal-title":"N Engl J Med"},{"issue":"11","key":"6786_CR30","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1101\/gr.105163.110","volume":"20","author":"NV Dharia","year":"2010","unstructured":"Dharia NV, Plouffe D, Bopp SE, Gonz\u00e1lez-P\u00e1ez GE, Lucas C, Salas C, Soberon V, Bursulaya B, Kochel TJ, Bacon DJ, Winzeler EA (2010) Genome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites. Genome Res 20(11):1534\u20131544","journal-title":"Genome Res"},{"key":"6786_CR31","doi-asserted-by":"crossref","unstructured":"Douroumis D, Fahr A (2013) Drug delivery strategies for poorly water-soluble drugs. Advances in pharmaceutical technology. Wiley 67\u201391:373\u2013400","DOI":"10.1002\/9781118444726"},{"issue":"20","key":"6786_CR32","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/jm060673d","volume":"49","author":"MGB Drew","year":"2006","unstructured":"Drew MGB, Metcalfe J, Dascombe MJ, Ismail FMD (2006) Reactions of artemisinin and arteether with acid: implications for stability and mode of antimalarial action. J Med Chem 49(20):6065\u20136073","journal-title":"J Med Chem"},{"key":"6786_CR33","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.theochem.2007.08.007","volume":"823","author":"MGB Drew","year":"2007","unstructured":"Drew MGB, Metcalfe J, Dascombe MJ, Ismail FMD (2007) De novo identification and stability of the artemisinin pharmacophore: studies of the reductive decomposition of deoxyartemisinins and deoxyarteethers and the implications for the mode of antimalarial action. J Mol Struct Theochem 823:34\u201346","journal-title":"J Mol Struct Theochem"},{"key":"6786_CR34","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/nature01813","volume":"424","author":"U Eckstein-Ludwig","year":"2003","unstructured":"Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O\u2019Neill PM, Bray PG, Ward SA, Krishna S (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature 424:957\u2013961","journal-title":"Nature"},{"issue":"1","key":"6786_CR35","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0035-9203(87)90305-1","volume":"81","author":"MD Edstein","year":"1987","unstructured":"Edstein MD, Veenendaal JR (1987) Chlorproguanil and chlorcycloguanil concentrations in human plasma and urine after Lapudrine administration. Trans R Soc Trop Med Hyg 81(1):136\u2013139","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6786_CR36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2125.1993.tb05685.x","volume":"35","author":"G Edwards","year":"1993","unstructured":"Edwards G, McGrath CS, Ward SA, Supanaranond W, Pukrittayakamee S, Davis TM, White NJ (1993) Interactions among primaquine, malaria infection and other antimalarials in Thai subjects. Br J Clin Pharmacol 35:193\u2013198","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"6786_CR37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1517\/17425247.4.4.403","volume":"4","author":"A Fahr","year":"2007","unstructured":"Fahr A, Liu X (2007) Drug delivery strategies for poorly water-soluble drugs. Expert Opin Drug Deliv 4(4):403\u2013416","journal-title":"Expert Opin Drug Deliv"},{"issue":"32","key":"6786_CR38","doi-asserted-by":"crossref","first-page":"8103","DOI":"10.1002\/chem.201800729","volume":"24","author":"T Fr\u00f6hlich","year":"2018","unstructured":"Fr\u00f6hlich T, Hahn F, Belmudes L, Leidenberger M, Friedrich O, Kappes B, Cout\u00e9 Y, Marschall M, Tsogoeva SB (2018) Synthesis of artemisinin-derived dimers, trimers and dendrimers: investigation of their antimalarial and antiviral activities including putative mechanisms of action. Chemistry 24(32):8103\u20138113","journal-title":"Chemistry"},{"key":"6786_CR39","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0731-7085(02)00678-7","volume":"31","author":"M Gabri\u0451ls","year":"2003","unstructured":"Gabri\u0451ls M, Plaizier-Vercammen J (2003) Physical and chemical evaluation of liposomes, containing artesunate. J Pharm Biomed Anal 31:655\u2013667","journal-title":"J Pharm Biomed Anal"},{"key":"6786_CR40","first-page":"CD004389","volume":"10","author":"GNL Galappaththy","year":"2013","unstructured":"Galappaththy GNL, Tharyan P, Kirubakaran R (2013) Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquine. Cochrane Database Syst Rev 10:CD004389","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"6786_CR41","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/1469-0691.12798","volume":"20","author":"S Gandra","year":"2014","unstructured":"Gandra S, Barter DM, Laxminarayan R (2014) Economic burden of antibiotic resistance: how much do we really know? Clin Microbiol Infect 20(10):973\u2013980","journal-title":"Clin Microbiol Infect"},{"key":"6786_CR42","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/138920009787846323","volume":"10","author":"A Gautam","year":"2009","unstructured":"Gautam A, Ahmedm T, BatraV PJ (2009) Pharmacokinetics and pharmacodynamics of endoperoxide antimalarials. Curr Drug Metab 10:289\u2013306","journal-title":"Curr Drug Metab"},{"issue":"2","key":"6786_CR43","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00003088-200847020-00002","volume":"47","author":"PI German","year":"2008","unstructured":"German PI, Aweeka FT (2008) Clinical pharmacology of artemisinin-based combination therapies. Clin Pharmacokinet 47(2):91\u2013102","journal-title":"Clin Pharmacokinet"},{"key":"6786_CR44","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/S0006-2952(98)00184-1","volume":"56","author":"H Ginsburg","year":"1998","unstructured":"Ginsburg H, Famin O, Zhang JM, Krugliak M (1998) Inhibition of glutathione-dependent degradation of heme by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol 56:1305\u20131313","journal-title":"Biochem Pharmacol"},{"key":"6786_CR45","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/00034983.2000.11813571","volume":"94","author":"NJ Gogtay","year":"2000","unstructured":"Gogtay NJ, KadamVS KDR, KanburA KKD, Kshirsagar NA (2000) Probable resistance to parenteral artemether in Plasmodium falciparum: case reports from Mumbai (Bombay), India. Ann Trop Med Parasitol 94:519\u2013520","journal-title":"Ann Trop Med Parasitol"},{"key":"6786_CR46","first-page":"CD008152","volume":"9","author":"PM Graves","year":"2012","unstructured":"Graves PM, Gelband H, Garner P (2012) Primaquine for reducing Plasmodium falciparum transmission. Cochrane Database Syst Rev 9:CD008152","journal-title":"Cochrane Database Syst Rev"},{"key":"6786_CR47","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJM197609302951406","volume":"295","author":"G Gregoriadis","year":"1976","unstructured":"Gregoriadis G (1976) The carrier potential of liposomes in biology and medicine (second of two parts). N Engl J Med 295:765\u2013770","journal-title":"N Engl J Med"},{"issue":"20","key":"6786_CR48","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1001\/jama.297.20.2264","volume":"297","author":"KS Griffith","year":"2007","unstructured":"Griffith KS, Lewis LS, Mali S, Parise ME (2007) Treatment of malaria in the United States: a systematic review. J Am Med Assoc 297(20):2264\u20132277","journal-title":"J Am Med Assoc"},{"issue":"3","key":"6786_CR49","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1128\/AAC.50.3.968-974.2006","volume":"50","author":"AK Harin","year":"2006","unstructured":"Harin AK, John R, Kerry L, Elizah D, Juliana H, Madhu P, Gregory MC, Kenneth FI, Timothy MED (2006) Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea. Antimicrob Agents Chemother 50(3):968\u2013974","journal-title":"Antimicrob Agents Chemother"},{"key":"6786_CR50","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jgar.2020.02.018","volume":"22","author":"K Harsha","year":"2020","unstructured":"Harsha K, Siddhesh J, Krishnapriya M, Mrunal A, Supriya S (2020) Investigation of pre-clinical pharmacokinetic parameters of atovaquone nanosuspension prepared using pH based precipitation method and its pharmacodynamic properties in a novel artemisinin combination. J Glob Antimicrob Resist 22:248\u2013256. https:\/\/doi.org\/10.1016\/j.jgar.2020.02.018","journal-title":"J Glob Antimicrob Resist"},{"issue":"5","key":"6786_CR51","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/156802606776743129","volume":"6","author":"RK Haynes","year":"2006","unstructured":"Haynes RK (2006) From artemisinin to new artemisinin antimalarials: biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements. Curr Top Med Chem 6(5):509\u2013537","journal-title":"Curr Top Med Chem"},{"key":"6786_CR52","doi-asserted-by":"crossref","unstructured":"Haynes RK, Cheu K-W, N\u2019Da D, Coghi P, Monti D (2013) Considerations on the mechanism of action of artemisinin antimalarials: part 1 - the \u2018carbon radical\u2019 and \u2018heme\u2019 hypotheses. Infect Disord Drug Targets 13(4):217\u2013277","DOI":"10.2174\/1871526513666131129155708"},{"issue":"3","key":"6786_CR53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1517\/13543784.2015.1000483","volume":"24","author":"J Held","year":"2015","unstructured":"Held J, Jeyaraj S, Kreidenweiss A (2015) Antimalarial compounds in phase II clinical development. Expert Opin Investig Drugs 24(3):363\u2013382","journal-title":"Expert Opin Investig Drugs"},{"key":"6786_CR54","unstructured":"Hunt NH, Stocker R (1990) Oxidative stress and the redox status of malaria-infected erythrocytes. Blood Cells 16(2\u20133):499\u2013530"},{"issue":"9","key":"6786_CR55","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1124\/dmd.30.9.1005","volume":"30","author":"KF Ilett","year":"2002","unstructured":"Ilett KF, Ethell BT, Maggs JL, Davis TM, Batty KT, Burchell B, Binh TQ, Thule TA, Hung NC, Pirmohamed M, Park BK, Edwards G (2002) Glucuronidation of dihydroartemisinin in vivo and by human liver microsomes and expressed UDP-glucuronosyltransferases. Drug Metab Dispos 30(9):1005\u20131012","journal-title":"Drug Metab Dispos"},{"key":"6786_CR56","first-page":"630","volume":"15","author":"Institute of Parasitic Diseases Chinese Academy of Medical Sciences","year":"1980","unstructured":"Institute of Parasitic Diseases Chinese Academy of Medical Sciences (1980) Experimental studies on chemotherapeutic effects and toxicities of a new antimalarial drug 7351 (author\u2019s transl). Yao Xue Xue Bao 15:630\u2013632","journal-title":"Yao Xue Xue Bao"},{"key":"6786_CR57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1074-5521(02)00117-5","volume":"9","author":"R Kannan","year":"2002","unstructured":"Kannan R, Sahal D, Chauhan VS (2002) Heme-artemisinin adducts are crucial mediators of the ability of artemisinin to inhibit heme polymerization. Chem Biol 9:321\u2013332","journal-title":"Chem Biol"},{"key":"6786_CR58","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/asia.201500347","volume":"10","author":"J Kim","year":"2015","unstructured":"Kim J, Yang J, Lee J, Choi G, Park D, Jo M, Choi S, Choy J (2015) 2D inorganic-antimalarial drug-polymer hybrid with pH responsive solubility. Chem Asian J 10:2264\u20132271","journal-title":"Chem Asian J"},{"key":"6786_CR59","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/ptr.2650090510","volume":"9","author":"GC Kirby","year":"1995","unstructured":"Kirby GC, Paine A, Warhurst DC, Noamese BK, Phillipson JD (1995) In vitro and in vivo antimalarial activity of cryptolepine, a plant-derived indoloquinoline. Phytother Res 9:359\u2013363","journal-title":"Phytother Res"},{"issue":"4","key":"6786_CR60","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00003088-199630040-00002","volume":"30","author":"S Krishna","year":"1996","unstructured":"Krishna S, White NJ (1996) Pharmacokinetics of quinine, chloroquine and amodiaquine: clinical implications. Clin Pharmacokinet 30(4):263\u2013299","journal-title":"Clin Pharmacokinet"},{"issue":"4\u20135","key":"6786_CR61","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drup.2004.07.001","volume":"7","author":"S Krishna","year":"2004","unstructured":"Krishna S, Uhlemann AC, Haynes RK (2004) Artemisinins: mechanisms of action and potential for resistance. Drug Resist Updat 7(4\u20135):233\u2013244","journal-title":"Drug Resist Updat"},{"key":"6786_CR62","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1475-2875-10-142","volume":"10","author":"C Lacaze","year":"2011","unstructured":"Lacaze C, Kauss T, Kiechel JR, Caminiti A, Fawaz F, Terrassin L, Cuart S, Grislain L, Navaratnam V, Ghezzoul B, Gaudin K, White NJ, Olliaro P, Millet P (2011) The initial pharmaceutical development of an artesunate\/amodiaquine oral formulation for the treatment of malaria: a public-private partnership. Malar J 10:142","journal-title":"Malar J"},{"key":"6786_CR63","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/polym11071162","volume":"11","author":"JH Lee","year":"2019","unstructured":"Lee JH, Kim HR, Lee JH, Lee SK, Chun Y, Han SO, Yoo HY, Park C, Kim SW (2019) Enhanced in-vitro hemozoin polymerization by optimized process using histidine-rich protein II (HRPII). Polymers 11:1162\u20131175","journal-title":"Polymers"},{"issue":"8","key":"6786_CR64","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1128\/AAC.46.8.2315-2320.2002","volume":"46","author":"B Lell","year":"2002","unstructured":"Lell B, Kremsner PG (2002) Clindamycin as an antimalarial drug: review of clinical trials. Antimicrob Agents Chemother 46(8):2315\u20132320","journal-title":"Antimicrob Agents Chemother"},{"key":"6786_CR65","first-page":"17","volume":"16","author":"GD Li","year":"1995","unstructured":"Li GD, Liu SQ, Ye XY, Qu FY (1995) Detection of 54-kDa protein overexpressed by chloroquine-resistant Plasmodium berghei ANKA strain in pyronaridine-resistant P. berghei ANKA strain. Zhongguo Yao Li Xue Bao 16:17\u201320","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"6786_CR66","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.2042-7158.1998.tb06173.x","volume":"50","author":"Q Li","year":"1998","unstructured":"Li Q, Peggins JO, Fleckenstein LL, Masonic K, Heiffer MH, Brewer TG (1998) The pharmacokinetics and bioavailability of dihydroartemisinin, meether, artemether, artesunic acid and artelinic acid in rats. J Pharm Pharmacol 50:173\u2013182","journal-title":"J Pharm Pharmacol"},{"key":"6786_CR67","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4269\/ajtmh.1996.54.205","volume":"54","author":"S Looareesuwan","year":"1996","unstructured":"Looareesuwan S, Kyle DE, Viravan C, Vanijanonta S, Wilairatana P, Wernsdorfer WH (1996) Clinical study of pyronaridine for the treatment of acute uncomplicated falciparum malaria in Thailand. Am J Trop Med Hyg 54:205\u2013209","journal-title":"Am J Trop Med Hyg"},{"key":"6786_CR68","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0035-9203(98)90807-0","volume":"92","author":"C Luxemburger","year":"1998","unstructured":"Luxemburger C, Brockman A, Silamut K, Nosten F, van Vugt M, Gimenez F, Chongsuphajaisiddhi T, White NJ (1998) Two patients with falciparum malaria and poor in vivo responses to artesunate. Trans R Soc Trop Med Hyg 92:668\u2013669","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6786_CR69","first-page":"85","volume":"46","author":"G Majori","year":"2004","unstructured":"Majori G (2004) Combined antimalarial therapy using artemisinin. Parasitologia 46:85\u201387","journal-title":"Parasitologia"},{"key":"6786_CR70","first-page":"49","volume-title":"Advances in planar lipid bilayers and liposomes","author":"K Makino","year":"2006","unstructured":"Makino K, Shibata A (2006) Surface properties of liposomes depending on their composition. In: Leitmannova Liu A (ed) Advances in planar lipid bilayers and liposomes. Elsevier, Amsterdam, pp 49\u201377"},{"issue":"5","key":"6786_CR71","doi-asserted-by":"crossref","first-page":"568","DOI":"10.4269\/ajtmh.2005.72.568","volume":"72","author":"W Marqui\u00f1o","year":"2005","unstructured":"Marqui\u00f1o W, Ylquimiche L, Hermenegildo Y, Palacios AM, Falcon\u00ed E, Cabezas C, Arr\u00f3spide N, Gutierrez S, Ruebush TK (2005) Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru. Am J Trop Med Hyg 72(5):568\u2013572","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"6786_CR72","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0035-9203(03)80040-8","volume":"97","author":"R McGready","year":"2003","unstructured":"McGready R, Keon NK, Villegas L, White NJ, Looareesuwan S, Nosten F (2003) Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report. Trans R Soc Trop Med Hyg 97(5):592\u2013594","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6786_CR73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1021\/ar7000843","volume":"41","author":"B Meunier","year":"2007","unstructured":"Meunier B (2007) Hybrid molecules with a dual mode of action: dream or reality? Acc Chem Res 41:69","journal-title":"Acc Chem Res"},{"key":"6786_CR74","doi-asserted-by":"crossref","unstructured":"Mohammadi S, Jafari B, Asgharian P, Martorell M, Sharifi-Rad J (2020) Medicinal plants used in the treatment of malaria: a key emphasis to Artemisia, Cinchona, Cryptolepis, and Tabebuia genera. Phytother Res 34(7):1556\u20131569","DOI":"10.1002\/ptr.6628"},{"key":"6786_CR75","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1186\/1475-2875-10-263","volume":"10","author":"CA Morris","year":"2011","unstructured":"Morris CA, Duparc S, Borghini-Fuhrer I, Jung D, Shin C, Fleckenstein L (2011) Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration. Malar J 10:263","journal-title":"Malar J"},{"issue":"7","key":"6786_CR76","first-page":"95","volume":"6","author":"AH Muder","year":"2014","unstructured":"Muder AH, Sunderland VB (2014) Effect of hydroxypropyl-\u03b2-cyclodextrin complexation on the aqueous solubility and stability of artesunate. Int J Pharm Pharm Sci 6(7):95\u201398","journal-title":"Int J Pharm Pharm Sci"},{"issue":"7","key":"6786_CR77","first-page":"1","volume":"14","author":"M Nigam","year":"2019","unstructured":"Nigam M, Atanassova M, Mishra AP, Pezzani R, Devkota HP, Plygun S, Salehi B, Setzer WN, Sharifi-Rad J (2019) Bioactive compounds and health benefits of Artemisia species. Nat Prod Commun 14(7):1\u201317","journal-title":"Nat Prod Commun"},{"issue":"24","key":"6786_CR78","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1056\/NEJMc0805011","volume":"359","author":"H Noedl","year":"2008","unstructured":"Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM (2008) Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359(24):2619\u20132620","journal-title":"N Engl J Med"},{"key":"6786_CR79","first-page":"891","volume":"65","author":"F Nosten","year":"1987","unstructured":"Nosten F, Imvithaya S, Vincenti M, Lebihan G, Hausler B, White NJ (1987) Malaria on the Thai-Burmese border: treatment of 5182 patients with mefloquine sulfadoxine-pyrimethamine. Bull World Health Organ 65:891\u2013896","journal-title":"Bull World Health Organ"},{"key":"6786_CR80","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/0140-6736(91)92798-7","volume":"337","author":"F Nosten","year":"1991","unstructured":"Nosten F, ter Kuile F, Chongsuphajaisiddhi T, Luxemburger C, Webster HK, Edstein M, Phaipun L, Thew KL, White NJ (1991) Mefloquine-resistant falciparum malaria on the Thai-Burmese border. Lancet 337:1140\u20131143","journal-title":"Lancet"},{"key":"6786_CR81","first-page":"95","volume-title":"Treatment and prevention of malaria antimalarial drug chemistry, action and use","author":"F Nosten","year":"2012","unstructured":"Nosten F, Phillips-Howard PA, Ter Kuile FO (2012) Other 4-methanolquinolines, amyl alcohols and phentathrenes: mefloquine, lumefantrine and halofantrine. In: Staines HM, Krishna S (eds) Treatment and prevention of malaria antimalarial drug chemistry, action and use. Springer, London, pp 95\u2013112"},{"key":"6786_CR82","first-page":"113","volume-title":"Treatment and prevention of malaria antimalarial drug chemistry, action and use","author":"A Nzila","year":"2012","unstructured":"Nzila A (2012) Antifolates: pyrimethamine, proguanil, sulphadoxine and dapsone. In: Staines HM, Krishna S (eds) Treatment and prevention of malaria antimalarial drug chemistry, action and use. Springer, London, pp 113\u2013126"},{"key":"6786_CR83","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijpharm.2016.11.015","volume":"516","author":"MA Obeid","year":"2017","unstructured":"Obeid MA, Khadra I, Mullen AB, Tate RJ, Ferro VA (2017a) The effects of hydration media on the characteristics of non-ionic surfactant vesicles (NISV) prepared by microfluidics. Int J Pharm 516:52\u201360","journal-title":"Int J Pharm"},{"key":"6786_CR84","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1021\/acs.molpharmaceut.7b00352","volume":"14","author":"MA Obeid","year":"2017","unstructured":"Obeid MA, Elburi A, Young LC, Mullen AB, Tate RJ, Ferro VA (2017b) Formulation of nonionic surfactant vesicles (NISV) prepared by microfluidics for therapeutic delivery of siRNA into cancer cells. Mol Pharm 14:2450\u20132458","journal-title":"Mol Pharm"},{"issue":"5","key":"6786_CR85","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0035-9203(03)80038-X","volume":"97","author":"CO Obonyo","year":"2003","unstructured":"Obonyo CO, Ochieng F, Taylor WR, Ochola SA, Mugitu K, Olliaro P, ter Kuile F, Oloo AJ (2003) Artesunate plus sulfadoxine-pyrimethamine for uncomplicated malaria in Kenyan children: a randomized, double-blind, placebo-controlled trial. Trans R Soc Trop Med Hyg 97(5):585\u2013591","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6786_CR86","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0035-9203(92)90533-I","volume":"86","author":"AM Oduola","year":"1992","unstructured":"Oduola AM, Sowunmi A, Milhous WK, Kyle DE, Martin RK, Walker O, Salako LA (1992) Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria. Trans R Soc Trop Med Hyg 86:123\u2013126","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6786_CR87","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1051\/parasite\/2018021","volume":"25","author":"M Ouji","year":"2018","unstructured":"Ouji M, Augereau JM, Paloque L, Benoit-Vical F (2018) Plasmodium falciparum resistance to artemisinin-based combination therapies: a sword of Damocles in the path toward malaria elimination. Parasite 25:24","journal-title":"Parasite"},{"key":"6786_CR88","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1021\/jm058288w","volume":"49","author":"IH Paik","year":"2006","unstructured":"Paik IH, Xie S, Shapiro TA, Labonte T, Sarjeant AAN, Baege AC, Posner GH (2006) Second generation, orally active, antimalarial, artemisinin-derived trioxane dimers with high stability, efficacy, and anticancer activity. J Med Chem 49:2731\u20132734","journal-title":"J Med Chem"},{"key":"6786_CR89","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2165\/00003495-199345030-00009","volume":"45","author":"KJ Palmer","year":"1993","unstructured":"Palmer KJ, Holliday SM, Brogden RN (1993) Mefloquine a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 45:430\u2013475","journal-title":"Drugs"},{"key":"6786_CR90","doi-asserted-by":"crossref","first-page":"19383","DOI":"10.1074\/jbc.274.27.19383","volume":"27","author":"AV Pandey","year":"1999","unstructured":"Pandey AV, Tekwani BL, Singh RL, Chauhan VS (1999) Artemisinin, an endoperoxide antimalarial, disrupts the hemoglobin catabolism and heme detoxification systems in malarial parasite. J Biol Chem 27:19383\u201319388","journal-title":"J Biol Chem"},{"key":"6786_CR91","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-2000-11106","volume":"66","author":"A Paulo","year":"2000","unstructured":"Paulo A, Gomes ET, Steele J, Warhurst DC, Houghton PJ (2000) Antiplasmodial activity of Cryptolepis sanguinolenta alkaloids from leaves and roots. Planta Med 66:30\u201334","journal-title":"Planta Med"},{"key":"6786_CR92","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ejmech.2017.09.040","volume":"40","author":"AN Pearce","year":"2017","unstructured":"Pearce AN, Kaiser M, Copp BR (2017) Synthesis and antimalarial evaluation of artesunate-polyamine and trioxolanepolyamine conjugates. Eur J Med Chem 40:595\u2013603","journal-title":"Eur J Med Chem"},{"key":"6786_CR93","first-page":"11","volume-title":"The current global malaria situation: malaria parasite biology, pathogenesis and protection","author":"IT Peter","year":"1998","unstructured":"Peter IT, Anatoli KK (1998) The current global malaria situation: malaria parasite biology, pathogenesis and protection. ASM Press, Washington, pp 11\u201322"},{"key":"6786_CR94","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4269\/ajtmh.2006.74.432","volume":"74","author":"W Piyaphanee","year":"2006","unstructured":"Piyaphanee W, Krudsood S, Tangpukdee N, Thanachartwet W, Silachamroon U, Phophak N, Duangdee C, Haoharn O, Faithong S, Wilairatana P, Leowattana W, Looareesuwan S (2006) Emergence and clearance of gametocytes in uncomplicated Plasmodium falciparum malaria. Am J Trop Med Hyg 74:432\u2013435","journal-title":"Am J Trop Med Hyg"},{"key":"6786_CR95","doi-asserted-by":"crossref","first-page":"e14501","DOI":"10.1371\/journal.pone.0014501","volume":"6","author":"Y Poravuth","year":"2011","unstructured":"Poravuth Y, Socheat D, Rueangweerayut R, Uthaisin C, Pyae Phyo A, Valecha N, Rao BH, Tjitra E, Purnama A, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L (2011) Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomised, double-blind, non-inferiority trial. PLoS One 6:e14501","journal-title":"PLoS One"},{"issue":"6","key":"6786_CR96","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1021\/ar020227u","volume":"37","author":"GH Posner","year":"2004","unstructured":"Posner GH, O\u2019Neill PM (2004) Knowledge of the proposed chemical mechanism of action and cytochrome P450 metabolism of antimalarial trioxanes like artemisinin allows rational design of new antimalarial peroxides. Acc Chem Res 37(6):397\u2013404","journal-title":"Acc Chem Res"},{"key":"6786_CR97","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/AAC.44.6.1680-1685.2000","volume":"44","author":"S Pukrittayakamee","year":"2000","unstructured":"Pukrittayakamee S, Chantra A, Simpson JA, Vanijanonta S, Clemens R, Looareesuwan S, White NJ (2000) Therapeutic responses to different antimalarial drugs in vivax malaria. Antimicrob Agents Chemother 44:1680\u20131685","journal-title":"Antimicrob Agents Chemother"},{"key":"6786_CR98","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.2008.79.378","volume":"79","author":"S Pukrittayakamee","year":"2008","unstructured":"Pukrittayakamee S, Imwong M, Singhasivanon P, Stepniewska K, Day NJ, White NJ (2008) Effects of different antimalarial drugs on gametocyte carriage in P. vivax malaria. Am J Trop Med Hyg 79:378\u2013384","journal-title":"Am J Trop Med Hyg"},{"key":"6786_CR99","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1080\/00034983.2001.11813635","volume":"95","author":"M Randrianarivelojosia","year":"2001","unstructured":"Randrianarivelojosia M, Raharimalala LA, Randrianasolo L, Ratsimbasoa A, Rason MA, Ariey F, Jambou R (2001) Madagascan isolates of Plasmodium falciparum showing low sensitivity to artemether in vitro. Ann Trop Med Parasitol 95:237\u2013243","journal-title":"Ann Trop Med Parasitol"},{"key":"6786_CR100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature10124","volume":"473","author":"R Rappuoli","year":"2011","unstructured":"Rappuoli R, Aderem A (2011) A 2020 vision for vaccines against HIV, tuberculosis and malaria. Nature 473:463\u2013469","journal-title":"Nature"},{"key":"6786_CR101","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1016\/j.bmc.2015.07.048","volume":"23","author":"C Reiter","year":"2015","unstructured":"Reiter C, Frohlich L, Gruber L, Hutterer C, Marschall M, Voigtl\u00e4nder C, Friedrich O, Kappes B, Efferth T, Tsogoeva SB (2015) Highly potent artemisinin-derived dimers and trimers: synthesis and evaluation of their antimalarial, antileukemia and antiviral activities. Bioorg Med Chem 23:5452\u20135458","journal-title":"Bioorg Med Chem"},{"key":"6786_CR102","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1056\/NEJMoa1007125","volume":"366","author":"R Rueangweerayut","year":"2012","unstructured":"Rueangweerayut R, Phyo A, Uthaisin C, Poravuth Y, Binh T, Tinto H, P\u00e9nali L, Valecha N, Tien N, Abdulla S, Borghini-Fuhrer I, Duparc S, Shin CS, Fleckenstein L (2012) Pyronaridine-artesunate versus mefloquine plus artesunate for malaria. N Engl J Med 366:1298\u20131309","journal-title":"N Engl J Med"},{"key":"6786_CR103","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/415680a","volume":"415","author":"J Sachs","year":"2002","unstructured":"Sachs J, Malaney P (2002) The economic and social burden of malaria. Nature 415:680\u2013685","journal-title":"Nature"},{"key":"6786_CR104","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1080\/00034983.2001.11813658","volume":"95","author":"F Sahr","year":"2001","unstructured":"Sahr F, Willoughby VR, Gbakima AA, Bockarie MJ (2001) Apparent drug failure following artesunate treatment of Plasmodium falciparum malaria in Freetown, Sierra Leone: four case reports. Ann Trop Med Parasitol 95:445\u2013449","journal-title":"Ann Trop Med Parasitol"},{"key":"6786_CR105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijmm.2012.07.009","volume":"302","author":"FC Schrader","year":"2012","unstructured":"Schrader FC, Marlene Barho M, Steiner I, Ortmann R, Schlitzer M (2012) The antimalarial pipeline \u2013 an update. Int J Med Microbiol 302:165\u2013171","journal-title":"Int J Med Microbiol"},{"issue":"2","key":"6786_CR106","first-page":"164","volume":"8","author":"D Setyawan","year":"2015","unstructured":"Setyawan D, Wardhana NK, Sari R (2015) Solubility, dissolution test and antimalarial activity of artesunate nicotinamide co-crystal prepared by solvent evaporation and slurry methods. Asian J Pharm Clin Res 8(2):164\u2013166","journal-title":"Asian J Pharm Clin Res"},{"key":"6786_CR107","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/jm4014778","volume":"57","author":"K Singh","year":"2014","unstructured":"Singh K, Kaur H, Smith P, de Kock C, Chibale K, Balzarini J (2014) Quinoline\u2212pyrimidine hybrids: synthesis, antiplasmodial activity, SAR, and mode of action studies. J Med Chem 57:435\u2013448","journal-title":"J Med Chem"},{"key":"6786_CR108","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2011.05.003","volume":"414","author":"JD Steyn","year":"2011","unstructured":"Steyn JD, Wiesner L, du Plessis LH, Grobler AF, Smith PJ, Chan WC, Haynes RK, Kotz\u00e9 AF (2011) Absorption of the novel artemisinin derivatives artemisone and artemiside: potential application of Pheroid technology. Int J Pharm 414:260\u2013266","journal-title":"Int J Pharm"},{"issue":"12","key":"6786_CR109","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1093\/infdis\/jiu341","volume":"210","author":"R Tahar","year":"2014","unstructured":"Tahar R, Almelli T, Debue C, Ngane VF, Allico JD, Youdom SW, Basco LK (2014) Randomized trial of artesunate-amodiaquine, atovaquone-proguanil, and artesunate-atovaquone-proguanil for the treatment of uncomplicated falciparum malaria in children. J Infect Dis 210(12):1962\u20131971","journal-title":"J Infect Dis"},{"key":"6786_CR110","first-page":"30","volume":"351","author":"AW Taylor-Robinson","year":"1998","unstructured":"Taylor-Robinson AW, Looker M (1998) Sensitivity of malaria parasites to nitric oxide at low oxygen tensions. Lancet 351:30","journal-title":"Lancet"},{"key":"6786_CR111","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1021\/cr500123g","volume":"114","author":"C Teixeira","year":"2014","unstructured":"Teixeira C, Vale N, P\u00e9rez B, Gomes A, Gomes JRB, Gomes P (2014) \u201cRecycling\u201d classical drugs for malaria. Chem Rev 114:1164\u20131220","journal-title":"Chem Rev"},{"issue":"6","key":"6786_CR112","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4269\/ajtmh.2001.65.717","volume":"65","author":"P Teja-Isavadharm","year":"2001","unstructured":"Teja-Isavadharm P, Watt G, Eamsila C, Jongsakul K, Li Q, Keeratithakul D, Sirisopana N, Luesutthiviboon L, Brewer TG, Kyle DE (2001) Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria. Am J Trop Med Hyg 65(6):717\u2013721","journal-title":"Am J Trop Med Hyg"},{"key":"6786_CR113","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-2836(03)00662-4","volume":"330","author":"T Tenson","year":"2003","unstructured":"Tenson T, Lovmar M, Ehrenberg M (2003) The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J Mol Biol 330:1005\u20131014","journal-title":"J Mol Biol"},{"key":"6786_CR114","first-page":"631","volume":"75","author":"FO ter Kuile","year":"1995","unstructured":"ter Kuile FO, Nosten F, Luxemburger C, Kyle D, Teja-Isavatharm P, Phaipun L, Price R, Chongsuphajaisiddhi T, White NJ (1995) Mefloquine treatment of acute falciparum malaria: a prospective study of non-serious adverse effects in 3673 patients. Bull World Health Organisation 75:631\u2013642","journal-title":"Bull World Health Organisation"},{"issue":"16","key":"6786_CR115","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1111\/febs.14127","volume":"284","author":"AM Thu","year":"2017","unstructured":"Thu AM, Phyo AP, Landier J, Parker DM, Nosten FH (2017) Combating multidrug-resistant Plasmodium falciparum malaria. FEBS J 284(16):2569\u20132578","journal-title":"FEBS J"},{"issue":"6","key":"6786_CR116","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s002280050658","volume":"55","author":"M van Vugt","year":"1999","unstructured":"van Vugt M, Edstein MD, Proux S, Lay K, Ooh M, Looareesuwan S, White NJ, Nosten F (1999) Absence of an interaction between artesunate and atovaquone-proguanil. Eur J Clin Pharmacol 55(6):469\u2013474","journal-title":"Eur J Clin Pharmacol"},{"issue":"12","key":"6786_CR117","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1086\/344901","volume":"35","author":"M van Vugt","year":"2002","unstructured":"van Vugt M, Leonardi E, Phaipun L, Slight T, Thway KL, McGready R, Brockman A, Villegas L, Looareesuwan S, White NJ, Nosten F (2002) Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. Clin Infect Dis 35(12):1498\u20131504","journal-title":"Clin Infect Dis"},{"issue":"11","key":"6786_CR118","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1128\/AAC.00510-08","volume":"52","author":"F Varotti","year":"2008","unstructured":"Varotti F, Botelho ACC, Andrade AA, de Paula RC, Fagundes EMS, Valverde A, Mayer LMU, Mendon\u00e7a JS, Marcus VN, Boechat N, Krettli AU (2008) Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate. Antimicrob Agents Chemother 52(11):3868\u20133874","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"6786_CR119","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/j.bmc.2014.03.030","volume":"22","author":"N Wang","year":"2014","unstructured":"Wang N, Wicht KJ, Shaban E, Ngoc TA, Wang M, Hayashi I, Hossain MI, Takemasa Y, Kaiser M, El Sayed IE, Egan TJ, Inokuchi T (2014) Synthesis, \u03b2-haematin inhibition, and in vitro antimalarial testing of isocryptolepine analogues: SAR study of indolo[3,2-c]quinolines with various substituents at C2, C6, and N11. Bioorg Med Chem 22(9):2629\u20132642","journal-title":"Bioorg Med Chem"},{"key":"6786_CR120","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ejmech.2015.07.009","volume":"101","author":"WA Wani","year":"2015","unstructured":"Wani WA, Jameel E, Baig U, Mumtazuddin S, Hun LT (2015) Ferroquine and its derivatives: new generation of antimalarial agents. Eur J Med Chem 101:534\u2013551","journal-title":"Eur J Med Chem"},{"key":"6786_CR121","first-page":"69","volume-title":"Treatment and prevention of malaria, antimalarial drug: chemistry, action and use","author":"NC Waters","year":"2012","unstructured":"Waters NC, Edstein MD (2012) In: Staines HM, Krishna S (eds) Treatment and prevention of malaria, antimalarial drug: chemistry, action and use. Springer, London, pp 69\u201394"},{"key":"6786_CR122","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1368-7646(98)80208-2","volume":"1","author":"NJ White","year":"1998","unstructured":"White NJ (1998) Preventing antimalarial drug resistance through combinations. Drug Resist Updat 1:3\u20139","journal-title":"Drug Resist Updat"},{"key":"6786_CR123","first-page":"301","volume":"41","author":"NJ White","year":"1999","unstructured":"White NJ (1999a) Delaying antimalarial drug resistance with combination chemotherapy. Parasitologia 41:301\u2013308","journal-title":"Parasitologia"},{"key":"6786_CR124","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1098\/rstb.1999.0426","volume":"354","author":"NJ White","year":"1999","unstructured":"White NJ (1999b) Antimalarial drug resistance and combination chemotherapy. Phil Trans R Soc Lond B 354:739\u2013749","journal-title":"Phil Trans R Soc Lond B"},{"key":"6786_CR125","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1126\/science.1155165","volume":"320","author":"NJ White","year":"2008","unstructured":"White NJ (2008) Qinghaosu (artemisinin): the price of success. Science 320:330\u2013334","journal-title":"Science"},{"key":"6786_CR126","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0169-4758(96)10055-7","volume":"12","author":"NJ White","year":"1996","unstructured":"White NJ, Olliaro PL (1996) Strategies for the prevention of anti-malarial drug resistance: rationale for combination chemotherapy for malaria. Parasitol Today 12:399\u2013401","journal-title":"Parasitol Today"},{"key":"6786_CR127","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0035-9203(97)90093-6","volume":"91","author":"PA Winstanley","year":"1997","unstructured":"Winstanley PA, Watkins WM, Muhia D, Szwandt S, Amukoye E, Marsh K (1997) Chlorproguanil-dapsone for uncomplicated falciparum malaria in young children: pharmacokinetics and therapeutic range. Trans R Soc Trop Med Hyg 91:322\u2013327","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"6786_CR128","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1371\/journal.pmed.0030373","volume":"3","author":"V Wiseman","year":"2006","unstructured":"Wiseman V, Kim M, Mutabingwa TK, Whitty CJ (2006) Cost-effectiveness study of three antimalarial drug combinations in Tanzania. PLoS Med 3:373","journal-title":"PLoS Med"},{"key":"6786_CR129","first-page":"ofz314","volume-title":"Open forum infectious diseases","author":"M Wojnarski","year":"2019","unstructured":"Wojnarski M, Lon C, Vanachayangkul P, Gosi P, Sok S, Rachmat A, Harrison D, Berjohn CM, Spring M, Chaoratanakawee S, Ittiverakul M (2019) Atovaquone-proguanil in combination with artesunate to treat multidrug-resistant P. falciparum malaria in Cambodia: an open-label randomized trial. In: Open forum infectious diseases, vol 6, 9. Oxford University Press, Oxford, p ofz314"},{"key":"6786_CR130","volume-title":"Antimalarial drug combination therapy report of a WHO technical consultation","author":"World Health Organization","year":"2001","unstructured":"World Health Organization (2001) Antimalarial drug combination therapy report of a WHO technical consultation. Roll Back Malaria\/World Health Organization, Geneva"},{"key":"6786_CR131","first-page":"2006","volume-title":"WHO calls for an immediate halt to provision of single-drug artemisinin malaria pills","author":"World Health Organization","year":"2006","unstructured":"World Health Organization (2006) WHO calls for an immediate halt to provision of single-drug artemisinin malaria pills. World Health Organization, Washington, p 2006"},{"key":"6786_CR132","unstructured":"World Health Organization (2007) WHO Resolution WHA6018 Malaria, including proposal for establishment of World Malaria Day In: Sixtieth World Health Assembly, Geneva, Resolutions and decisions, annexes Geneva: World Health Organization; 2007 (WHA60\/2007\/REC\/1)"},{"key":"6786_CR133","volume-title":"WHO guidelines for the treatment of malaria","author":"World Health Organization","year":"2010","unstructured":"World Health Organization (2010) WHO guidelines for the treatment of malaria, 2nd edn. World Health Organization, Geneva","edition":"2"},{"key":"6786_CR134","volume-title":"Malaria Policy Advisory Committee Meeting WHO Evidence Review Group: the safety and effectiveness of single dose primaquine as a P. falciparum gametocytocide","author":"World Health Organization","year":"2012","unstructured":"World Health Organization (2012) Malaria Policy Advisory Committee Meeting WHO Evidence Review Group: the safety and effectiveness of single dose primaquine as a P. falciparum gametocytocide. World Health Organization, Geneva"},{"key":"6786_CR135","unstructured":"World Health Organization (2015) WHO guidelines for the treatment of malaria, 3rd edition,\u00a0https:\/\/extranet.who.int\/iris\/restricted\/bitstream\/handle\/10665\/162441\/9789241549127_eng.pdf. Accessed 3 Jul 2020"},{"key":"6786_CR136","doi-asserted-by":"crossref","DOI":"10.30875\/50d27d62-en","volume-title":"World malaria report 2017","author":"World Health Organization","year":"2017","unstructured":"World Health Organization (2017) World malaria report 2017. World Health Organization, Geneva"},{"key":"6786_CR137","doi-asserted-by":"crossref","DOI":"10.30875\/7e6f8c91-en","volume-title":"World malaria report 2019","author":"World Health Organization","year":"2019","unstructured":"World Health Organization (2019) World malaria report 2019. World Health Organization, Geneva"},{"key":"6786_CR138","unstructured":"World Health Organization (2020). Q&A on the malaria vaccine implementation programme (MVIP). Retrieved from https:\/\/www.who.int\/malaria\/media\/malaria-vaccine-implementation-qa\/en\/ (accessed on 30 Mar 2020)"},{"key":"6786_CR139","first-page":"87","volume":"9","author":"LJ Wu","year":"1988","unstructured":"Wu LJ (1988) Effects of large doses of pyronaridine and chloroquine on the ultrastructure of the erythrocytic stages of pyronaridine-resistant line of Plasmodium berghei (in Chinese). Zhongguo Yao Li Xue Bao 9:87\u201389","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"6786_CR140","first-page":"359","volume":"11","author":"XY Ye","year":"1990","unstructured":"Ye XY, Shao BR (1990) Tissue schizontocidal action and acute toxicity of trifluoroacetyl primaquine in Chinese. Zhongguo Yao Li Xue Bao 11:359\u2013362","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"6786_CR141","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.powtec.2009.09.004","volume":"197","author":"X Zhang","year":"2009","unstructured":"Zhang X, Liu J, Qiao H, Liu H, Ni J, Zhang W, Shi Y (2009) Formulation optimization of dihydroartemisinin nanostructured lipid carrier using response surface methodology. Powder Technol 197:120\u2013128","journal-title":"Powder Technol"},{"issue":"4","key":"6786_CR142","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00003088-198611040-00003","volume":"11","author":"J Zuidema","year":"1986","unstructured":"Zuidema J, Hilbers-Modderman ESM, Merkus FWHM (1986) Clinical pharmacokinetics of dapsone. Clin Pharmacokinet 11(4):299\u2013315","journal-title":"Clin Pharmacokinet"}],"container-title":["Parasitology Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-020-06786-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00436-020-06786-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00436-020-06786-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T02:44:47Z","timestamp":1744166687000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00436-020-06786-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":142,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["6786"],"URL":"https:\/\/doi.org\/10.1007\/s00436-020-06786-1","relation":{},"ISSN":["0932-0113","1432-1955"],"issn-type":[{"value":"0932-0113","type":"print"},{"value":"1432-1955","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,7]]},"assertion":[{"value":"30 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}